Published in Ann Rheum Dis on October 01, 1981
Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome. Clin Exp Immunol (2008) 1.05
Transient neonatal Behcet's disease. Arch Dis Child (1986) 0.96
The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease. Noro Psikiyatr Ars (2014) 0.78
Behçet's syndrome. J R Soc Med (1984) 0.75
Transient neonatal Behcet's disease. BMJ Case Rep (2013) 0.75
Behçet's syndrome in pregnancy. Obstet Med (2010) 0.75
Recurrent vulvo-vaginal ulceration--Behçet's syndrome. Ulster Med J (1987) 0.75
Neonatal Behçet's disease without maternal history. Clin Rheumatol (2011) 0.75
Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med (1974) 6.77
Behçet's syndrome with arthritis. Ann Rheum Dis (1969) 5.99
Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest (1974) 5.81
Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) (1975) 5.68
Clinical Studies on Behçet's Syndrome. Ann Rheum Dis (1963) 4.61
Behçet disease (Behçet syndrome). Semin Arthritis Rheum (1979) 3.88
DISCOID LUPUS IN A NEWBORN INFANT OF A MOTHER WITH LUPUS ERYTHEMATOSUS. Pediatrics (1964) 1.83
Specific histocompatibility antigens associated with Behçet's disease. Am J Ophthalmol (1975) 1.63
Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. N Engl J Med (1977) 1.44
Neuro-Behçet's syndrome in the United Arab Republic. Eur Neurol (1973) 1.27
The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behçet's disease. Am J Med (1979) 1.24
Further investigations on the virus of Behçet's disease. Am J Ophthalmol (1956) 1.13
Behçet's disease. Br Med J (1979) 1.12
Familial Behçet's syndrome. Br J Dermatol (1976) 1.02
Behçet's syndrome. Report of a case associated with pericardial effusion and cryoglobulinemia treated with indomethacin. Am J Med (1979) 0.88
Behçet's syndrome: a family study and the elucidation of a genetic role. Ann Rheum Dis (1979) 0.87
Letter: Granulocyte platelet rosettes. N Engl J Med (1973) 0.83
Hyperkalemic periodic paralysis starting at age 48. Br Med J (1968) 0.81
Behçet's syndrome associated with pregnancy. Obstet Gynecol (1979) 0.80
Familial Behcet's syndrome. Cutis (1978) 0.80
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
CDKN2A mutations in multiple primary melanomas. N Engl J Med (1998) 3.52
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52
Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science (1995) 3.24
Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet (1993) 3.11
Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) (1991) 2.87
Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med (1999) 2.81
Fibromyalgia 20 years later: what have we really accomplished? J Rheumatol (1995) 2.77
A uniform deleting element mediates the loss of kappa genes in human B cells. Nature (1985) 2.65
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol (1999) 2.50
Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein. Nature (1999) 2.32
The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol (1990) 2.11
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
The natural disease course of ankylosing spondylitis. Arthritis Rheum (1983) 2.10
A 40-100 MHz B-scan ultrasound backscatter microscope for skin imaging. Ultrasound Med Biol (1995) 2.10
Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med (1993) 1.95
Wasp recruitment to the T cell:APC contact site occurs independently of Cdc42 activation. Immunity (2001) 1.93
Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet (2001) 1.82
The belt sign in scleroderma. J Rheumatol (1990) 1.78
Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin Immunol (2000) 1.77
Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med (1995) 1.73
Fulminant colitis complicating gold therapy. J Rheumatol (1980) 1.71
Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation. Blood (1990) 1.68
The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65
Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum (1984) 1.58
Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise. J Rheumatol (1992) 1.57
Multiple-crystal acute polyarthritis. Ann Rheum Dis (1983) 1.57
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet (1990) 1.56
Reinstitution of allopurinol therapy for gouty arthritis after cutaneous reactions. Can Med Assoc J (1980) 1.54
Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy. J Rheumatol (1991) 1.53
X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics (1989) 1.49
SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem (1999) 1.48
The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage (1995) 1.45
Does high-frequency (40-60 MHz) ultrasound imaging play a role in the clinical management of cutaneous melanoma? Ann Plast Surg (1995) 1.43
Skeletal muscle infarction in diabetes mellitus. J Rheumatol (2000) 1.42
SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol (1998) 1.41
Diagnosis and management of long-standing benign oral ulceration. Laryngoscope (1980) 1.41
The intersectin 2 adaptor links Wiskott Aldrich Syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med (2001) 1.40
Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med (1996) 1.34
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology (1998) 1.32
Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet (1996) 1.31
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum (1994) 1.28
Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem (1991) 1.28
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia (2010) 1.28
Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur J Immunol (1999) 1.27
HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum (1992) 1.27
Multiple tendon rupture at unusual sites in rheumatoid arthritis. J Rheumatol (1987) 1.26
Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome. Proc Natl Acad Sci U S A (1987) 1.23
Spa treatment in arthritis: a rheumatologist's view. J Rheumatol (1991) 1.23
Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum (1994) 1.20
An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med (1986) 1.19
Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum (1986) 1.18
Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of human autoimmune responses. J Immunol (1989) 1.17
Erosive azotemic osteoarthropathy. Arthritis Rheum (1984) 1.13
Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases. J Clin Invest (1991) 1.12
Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein-I-related gene product involved in the induction of cell proliferation. Biochem J (1994) 1.12
Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum Mol Genet (1995) 1.11
Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol (2001) 1.11
Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol (1983) 1.11
Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res (1993) 1.11
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.10
Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J Clin Invest (1992) 1.08
Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun (2012) 1.08
Variability of skin scores and clinical measurements in scleroderma. J Rheumatol (1995) 1.08
Neurologic complications associated with gold therapy for rheumatoid arthritis. J Rheumatol (1984) 1.07
SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages. J Biol Chem (1999) 1.06
Family physicians' knowledge of malignant melanoma. J Am Acad Dermatol (1997) 1.06
Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem (1997) 1.06
Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. Clin Immunol Immunopathol (1994) 1.05
Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function: studies in motheaten mice. J Immunol (2000) 1.05
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol (1991) 1.04
Fine mapping the TAGAP risk locus in rheumatoid arthritis. Genes Immun (2011) 1.04
The human kappa deleting element and the mouse recombining segment share DNA sequence homology. Nucleic Acids Res (1987) 1.01
The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J Biol Chem (1996) 1.01
Clinical forms of meningococcal arthritis: a study of five cases. J Rheumatol (1980) 1.01
Use of host factors to identify people at high risk for cutaneous malignant melanoma . CMAJ (1992) 1.00
Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med Biol (1996) 0.99
Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut (2001) 0.99
A highly informative probe for two polymorphic Vh gene regions that contain one or more autoantibody-associated Vh genes. J Clin Invest (1989) 0.98
Cholesterol crystals in osteoarthritic joint effusions. J Rheumatol (1981) 0.98
Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J Immunol (1999) 0.97
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. J Rheumatol (1991) 0.97
A controlled study of the long-term prognosis of adult Still's disease. Am J Med (1995) 0.97
Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Biochem Cell Biol (1989) 0.96
Possible deletion of a developmentally regulated heavy-chain variable region gene in autoimmune diseases. Proc Natl Acad Sci U S A (1990) 0.96
Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol (1997) 0.95
Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. Hum Pathol (2001) 0.95
Preliminary report on the Mount Sinai Hospital Inflammatory Bowel Disease Genetics Project. Dis Colon Rectum (1997) 0.94
Molecular characterization of the human immunoglobulin V lambda I germline gene repertoire. Mol Immunol (1992) 0.94
Metastatic carcinomatous arthritis and carcinoma of the lung. A report of two cases diagnosed by synovial fluid cytology. J Rheumatol (1980) 0.93
Lymphadenosis benigna cutis resulting from Borrelia infection (Borrelia lymphocytoma). J Am Acad Dermatol (1991) 0.93
The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J Exp Med (1997) 0.93
Regulation of Src homology 2-containing tyrosine phosphatase 1 during activation of human neutrophils. Role of protein kinase C. J Biol Chem (1997) 0.93
Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol (1994) 0.93
An experiment in reducing interobserver variability of the examination for joint tenderness. J Rheumatol (1988) 0.92
Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction. Hum Genet (1989) 0.92
Apatite-associated arthropathy: a clinical study of 14 cases and of 2 patients with calcific bursitis. J Rheumatol (1980) 0.92